HAFC Stock Analysis: Hanmi Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 916m USD | 12M Return: 30.5% | US4104952043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.28M
EPS Trend: 11.2%
Qual. Beats: 0
Rev. Trend: 45.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hanmi Financial Corporation is the holding company for Hanmi Bank, a U.S. commercial bank providing business banking products and services. Founded in 1982 and headquartered in Los Angeles, California, the company operates in the regional banking sector, which typically focuses on deposit gathering and commercial lending within defined geographic markets rather than the nationwide investment banking or capital markets activities of money center banks.
The company generates revenue primarily through net interest income from a diversified lending portfolio. Its loan offerings include commercial real estate, construction, residential property, and commercial and industrial loans, as well as equipment lease financing. On the funding side, Hanmi Bank provides a standard range of deposit products, including noninterest-bearing checking, negotiable order of withdrawal (NOW), savings, money market accounts, and certificates of deposit (CDs).
In addition to traditional banking, the company offers specialized services such as Small Business Administration (SBA) loans-a federal program under which loans to small businesses are partially guaranteed by the U.S. government-and international trade finance products, including letters of credit and import/export financing, which support cross-border commerce for business clients.
- Net interest margin expands as Fed rate cuts pause
- Commercial real estate loan portfolio faces credit quality pressure
- Deposit costs rise amid regional bank funding competition
| Net Income: 89.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 2.29 > 1.0 |
| NWC/Revenue: -1.44k% < 20% (prev -1.28k%; Δ -157.2% < -1%) |
| CFO/TA 0.03 > 3% & CFO 214.2m > Net Income 89.4m |
| Net Debt (-1.10b) to EBITDA (66.7m): -16.46 < 3 |
| Current Ratio: 0.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.8m) vs 12m ago -0.94% < -2% |
| Gross Margin: 56.36% > 18% (prev 53.93%; Δ 2.43% > 0.5%) |
| Asset Turnover: 4.86% > 50% (prev 5.49%; Δ -0.63% > 0%) |
| Interest Coverage Ratio: 0.40 > 6 (EBIT TTM 66.6m / Interest Expense TTM 164.8m) |
| A: -0.69 (Total Current Assets 1.43b - Total Current Liabilities 6.98b) / Total Assets 8.00b |
| B: 0.05 (Retained Earnings 423.5m / Total Assets 8.00b) |
| C: 0.01 (EBIT TTM 66.6m / Avg Total Assets 7.93b) |
| D: 0.11 (Book Value of Equity 812.7m / Total Liabilities 7.19b) |
| Altman-Z'' = -4.21 = D |
| DSRI: 0.44 (Receivables 24.6m/63.3m, Revenue 385.8m/431.9m) |
| GMI: 0.96 (GM 53.93% / 56.36%) |
| AQI: 0.99 (AQ_t 0.82 / AQ_t-1 0.83) |
| SGI: 0.89 (Revenue 385.8m / 431.9m) |
| TATA: -0.02 (NI 89.4m - CFO 214.2m) / TA 8.00b) |
| Beneish M = -3.61 (Cap -4..+1) = AAA |
As of October 06, 2026, the stock is trading at USD 31.50 with a total of 231,560 shares traded. Over the past week, the price has changed by -0.32%, over one month by -0.60%, over three months by -2.16% and over the past year by +30.50%.
Current recommended Stop Loss: 30.70 (which is 2.5% or 1.3 ATR below the current price).
Hanmi Financial has received a consensus analysts rating of 3.75. Therefore, it is recommended to hold HAFC.
- StrongBuy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 34.3 | 8.7% |
P/E Trailing = 10.5102
P/E Forward = 8.6207
P/S = 3.2965
P/B = 1.1521
P/EG = 1.3855
Revenue TTM = 385.8m USD
EBIT TTM = 66.6m USD
EBITDA TTM = 66.7m USD
Long Term Debt = 130.8m USD (from longTermDebt, last quarter)
Short Term Debt = 150.0m USD (from shortTermDebt, last fiscal year)
Debt = 130.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.10b USD (calculated: Debt 130.8m - CCE 1.23b)
Enterprise Value = 916.2m USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.40 (Ebit TTM 66.6m / Interest Expense TTM 164.8m)
EV/FCF = 4.34x (Enterprise Value 916.2m / FCF TTM 211.0m)
FCF Yield = 23.03% (FCF TTM 211.0m / Enterprise Value 916.2m)
FCF Margin = 54.69% (FCF TTM 211.0m / Revenue TTM 385.8m)
Net Margin = 23.16% (Net Income TTM 89.4m / Revenue TTM 385.8m)
Gross Margin = 56.36% ((Revenue TTM 385.8m - Cost of Revenue TTM 168.4m) / Revenue TTM)
Gross Margin QoQ = 29.92% (prev 61.87%)
Tobins Q-Ratio = 0.11 (Enterprise Value 916.2m / Total Assets 8.00b)
Interest Expense / Debt = 126.0% (Interest Expense 164.8m / Debt 130.8m)
Taxrate = 27.96% (34.7m / 124.0m)
NOPAT = 48.0m (EBIT 66.6m * (1 - 27.96%))
Current Ratio = 0.20 (Total Current Assets 1.43b / Total Current Liabilities 6.98b)
Debt / Equity = 0.16 (Debt 130.8m / totalStockholderEquity, last quarter 812.7m)
Debt / EBITDA = -16.46 (Net Debt -1.10b / EBITDA 66.7m)
Debt / FCF = -5.20 (Net Debt -1.10b / FCF TTM 211.0m)
Total Stockholder Equity = 797.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.13% (Net Income 89.4m / Total Assets 8.00b)
RoE = 11.20% (Net Income TTM 89.4m / Total Stockholder Equity 797.9m)
RoCE = 7.17% (EBIT 66.6m / Capital Employed (Equity 797.9m + L.T.Debt 130.8m))
RoIC = 4.17% (NOPAT 48.0m / Invested Capital 1.15b)
WACC = 7.08% (E(916.2m)/V(1.05b) * Re(8.09%) + (debt cost/tax rate unavailable))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.53 | Cagr: -0.52%
[DCF] Terminal Value 77.97% ; FCFF base≈137.3m ; Y1≈157.4m ; Y5≈231.7m
[DCF] Fair Price = 154.6 (EV 3.49b - Net Debt -1.10b = Equity 4.58b / Shares 29.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 11.20 | EPS CAGR: 1.63% | SUE: 0.35 | # QB: 0
Revenue Correlation: 45.23 | Revenue CAGR: 2.58% | SUE: -0.29 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.81 | Chg30d=+0.00% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=3.18 | Chg30d=-0.31% | Revisions=+17% | GrowthEPS=+26.7% | GrowthRev=+9.5%
EPS next Year (2027-12-31): EPS=3.37 | Chg30d=+0.00% | Revisions=-50% | GrowthEPS=+6.0% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: -18% (up=3, down=5)